SCHEMBL2883956

SCHEMBL2883956

CN1CC[C@H](C[O])C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1428205 1.00
SCHEMBL1317319 0.86
SCHEMBL375489 0.85
SCHEMBL27814598 0.85
SCHEMBL2971141 0.83 CHRM5 (0.38)
SCHEMBL3936495 0.80
SCHEMBL2385653 0.80
SCHEMBL2601105 0.79
SCHEMBL22458183 0.79
SCHEMBL2978622 0.78 NCF1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8338460-B2 3-({4-[2-(dimethylamino)ethoxy]phenyl}thio)-N-(3-methyl-1,2,4-thiadiazol-5-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)thio]pyridine-2-carboxamide; glucokinase activator; antidiabetic, obesity MSD K. K. (JP) 2012-12-25 US disclosed
EP-2077266-B1 2-PYRIDINECARBOXAMIDE DERIVATIVE HAVING GK-ACTIVATING ACTIVITY MSD KK (JP) 2012-07-25 EP disclosed
US-20100261699-A1 N-PYRAZOLE-2-PYRIDINE CARBOXAMIDE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
EP-2236507-A1 N-PYRAZOLE-2-PYRIDINECARBOXAMIDE DERIVATIVE Banyu Pharmaceutical Co., Ltd. (JP) 2010-10-06 EP disclosed
EP-2077266-A1 2-PYRIDINECARBOXAMIDE DERIVATIVE HAVING GK-ACTIVATING ACTIVITY BANYU PHARMACEUTICAL CO., LTD. (JP) 2009-07-08 EP disclosed
US-20080090799-A1 2-PYRIDINECARBOXAMIDE DERIVATIVE HAVING GK-ACTIVATING EFFECT MSD K.K. (JP) 2008-04-17 US disclosed